The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: An updated meta-analysis in 49 279 subjects

Human Molecular Genetics

Volumn 18, Issue 13, 2009, Pages 2495-2501

  Choquet, Hélène ^a   Cavalcanti Proença, Christine ^a   Lecoeur, Cécile ^a   Dina, Christian ^a   Cauchi, Stéphane ^a   Vaxillaire, Martine ^a   Hadjadj, Samy ^b   Horber, Fritz ^c,t   Potoczna, Natasha ^c   Charpentier, Guillaume ^d   Ruiz, Juan ^e   Hercberg, Serge ^f   Maimaitiming, Suliya ^g,h   Roussel, Ronan ^g,h,i   Boenhnke, Michael ^j   Jackson, Anne U ^j   Patsch, Wolfgang ^k   Krempler, Franz ^l   Voight, Benjamin F ^m,n   Altshuler, David ^m,n,o   Groop, Leif ^p,q   Thorleifsson, Gudmar ^r   Steinthorsdottir, Valgerdur ^r   Stefansson, Kari ^r   Balkau, Beverley ^g   Froguel, Philippe ^a,s   Meyre, David ^a   more..

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c Medical Department   (Switzerland)

^d CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f Institut National de la Recherche Agronomique   (France)

^g INSERM   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ BICHAT HOSPITAL   (France)

^j UNIVERSITY OF MICHIGAN   (United States)

^k PARACELSUS MEDICAL UNIVERSITY   (Austria)

^l Krankenhaus Hallein   (Austria)

^m MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^o HARVARD MEDICAL SCHOOL   (United States)

^p LUND UNIVERSITY HOSPITAL   (Sweden)

^q HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^r DECODE GENETICS   (Iceland)

^s HAMMERSMITH HOSPITAL   (United Kingdom)

^t UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE RESISTANCE; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67449098254     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp169     Document Type: Article

References (48)

1. Kiberstis, P.A. (2005) A surfeit of suspects. Science, 307, 369.
2. Bailes, B.K. (2002) Diabetes mellitus and its chronic complications. AORN J., 76, 266-276. 278-282; quiz 283-266.
3. Lange, E.M., Sun, J., Lange, L.A., Zheng, S.L., Duggan, D., Carpten, J.D., Gronberg, H., Isaacs, W.B., Xu, J. and Chang, B.L. (2008) Family-based samples can play an important role in genetic association studies. Cancer Epidemiol. Biomarkers Prev., 17, 2208-2214.
4. Florez, J.C. (2008) The genetics of type 2 diabetes: A realistic appraisal circa 2008. J. Clin. Endocrinol. Metab, 93, 4633-4642.
5. Hirschhorn, J.N., Lohmueller, K., Byrne, E. and Hirschhorn, K. (2002) A comprehensive review of genetic association studies. Genet. Med., 4, 45-61.
6. Cauchi, S., Nead, K.T., Choquet, H., Horber, F., Potoczna, N., Balkau, B., Marre, M., Charpentier, G., Froguel, P. and Meyre, D. (2008) The genetic susceptibility to type 2 diabetes may be modulated by obesity status: Implications for association studies. BMC Med. Genet., 9, 45.
7. Meyre, D., Bouatia-Naji, N., Vatin, V., Veslot, J., Samson, C., Tichet, J., Marre, M., Balkau, B. and Froguel, P. (2007) ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia, 50, 2090-2096.
8. Vaxillaire, M., Veslot, J., Dina, C., Proenca, C., Cauchi, S., Charpentier, G., Tichet, J., Fumeron, F., Marre, M., Meyre, D. et al. (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes, 57, 244-254.
9. Yamaguchi, S., Yamada, Y., Matsuo, H., Segawa, T., Watanabe, S., Kato, K., Yokoi, K., Ichihara, S., Metoki, N., Yoshida, H. et al. (2007) Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus. Int. J. Mol. Med., 19, 631-637.
10. Barroso, I., Luan, J., Wheeler, E., Whittaker, P., Wasson, J., Zeggini, E., Weedon, M.N., Hunt, S., Venkatesh, R., Frayling, T.M. et al. (2008) Population-specific risk of type 2 diabetes (T2D) conferred by HNF4A P2 promoter variants: A lesson for replication studies. Diabetes, 57, 3161-3165.
11. Yasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M., Ogawa, H., Okumura, K., Mukoyama, M. and Nakao, K. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 90, 195-203.
12. Sudoh, T., Maekawa, K., Kojima, M., Minamino, N., Kangawa, K. and Matsuo, H. (1989) Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem. Biophys. Res. Commun., 159, 1427-1434.
13. Yandle, T.G. (1994) Biochemistry of natriuretic peptides. J. Intern. Med., 235, 561-576.
14. Maisel, A. (2002) B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient. Rev. Cardiovasc. Med., 3 (Suppl. 4), S10-S17.
15. Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M. and Nakao, K. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 88, 82-91.
16. Tsutamoto, T., Wada, A., Sakai, H., Ishikawa, C., Tanaka, T., Hayashi, M., Fujii, M., Yamamoto, T., Dohke, T., Ohnishi, M. et al. (2006) Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J. Am. Coll. Cardiol., 47, 582-586.
17. Wang, T.J., Larson, M.G., Levy, D., Benjamin, E.J., Leip, E.P., Wilson, P.W. and Vasan, R.S. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation, 109, 594-600.
18. Wang, T.J., Larson, M.G., Levy, D., Leip, E.P., Benjamin, E.J., Wilson, P.W., Sutherland, P., Omland, T. and Vasan, R.S. (2002) Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am. J. Cardiol., 90, 254-258.
19. McCord, J., Mundy, B.J., Hudson, M.P., Maisel, A.S., Hollander, J.E., Abraham, W.T., Steg, P.G., Omland, T., Knudsen, C.W., Sandberg, K.R. et al. (2004) Relationship between obesity and B-type natriuretic peptide levels. Arch. Intern. Med., 164, 2247-2252.
20. Lafontan, M., Moro, C., Berlan, M., Crampes, F., Sengenes, C. and Galitzky, J. (2008) Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol. Metab., 19, 130-137.
21. Sengenes, C., Berlan, M., De Glisezinski, I., Lafontan, M. and Galitzky, J. (2000) Natriuretic peptides: A new lipolytic pathway in human adipocytes. FASEB J., 14, 1345-1351.
22. Meirhaeghe, A., Sandhu, M.S., McCarthy, M.I., de Groote, P., Cottel, D., Arveiler, D., Ferrieres, J., Groves, C.J., Hattersley, A.T., Hitman, G.A. et al. (2007) Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum. Mol. Genet., 16, 1343-1350.
23. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T., de Bakker, P.I., Abecasis, G.R., Almgren, P., Andersen, G. et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet., 40, 638-645.
24. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J., Kathiresan, S., Hirschhorn, J.N., Daly, M.J. et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 316, 1331-1336.
25. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., Erdos, M.R., Stringham, H.M., Chines, P.S., Jackson, A.U. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316 1341-1345.
26. Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G.B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S. et al. (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770-775.
27. Thorleifsson, G., Walters, G.B., Gudbjartsson, D.F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius, S., Jonsdottir, I. et al. (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet., 41, 18-24.
28. Chanock, S.J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D.J., Thomas, G., Hirschhorn, J.N., Abecasis, G., Altshuler, D., Bailey-Wilson, J.E. et al. (2007) Replicating genotype-phenotype associations. Nature, 447, 655-660.
29. Spielman, R.S. and Ewens, W.J. (1996) The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59, 983-989.
30. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C. et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet., 26, 76-80.
31. Gloyn, A.L., Weedon, M.N., Owen, K.R., Turner, M.J., Knight, B.A., Hitman, G., Walker, M., Levy, J.C., Sampson, M., Halford, S. et al. (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes, 52, 568-572.
32. Sandhu, M.S., Weedon, M.N., Fawcett, K.A., Wasson, J., Debenham, S.L., Daly, A., Lango, H., Frayling, T.M., Neumann, R.J., Sherva, R. et al. (2007) Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet., 39, 951-953.
33. Todd, J.A. (2006) Statistical false positive or true disease pathway? Nat. Genet., 38, 731-733.
34. Moonesinghe, R., Khoury, M.J., Liu, T. and Ioannidis, J.P. (2008) Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc. Natl Acad. Sci. USA, 105, 617-622.
35. McAteer, J.B., Prudente, S., Bacci, S., Lyon, H.N., Hirschhorn, J.N., Trischitta, V. and Florez, J.C. (2008) The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: Evidence from an updated meta-analysis in 42,042 subjects. Diabetes, 57, 1125-1130.
36. Levin, E.R., Gardner, D.G. and Samson, W.K. (1998) Natriuretic peptides. N. Engl. J. Med., 339, 321-328.
37. Doria, A., Patti, M.E. and Kahn, C.R. (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab., 8, 186-200.
38. Florez, J.C. (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes? Diabetologia, 51, 1100-1110.
39. Meyre, D., Bouatia-Naji, N., Tounian, A., Samson, C., Lecoeur, C., Vatin, V., Ghoussaini, M., Wachter, C., Hercberg, S., Charpentier, G. et al. (2005) Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat. Genet., 37, 863-867.
40. Newton-Cheh, C., Larson, M.G., Vasan, R.S., Levy, D., Bloch, K.D., Surti, A., Guiducci, C., Kathiresan, S., Benjamin, E.J., Struck, J. et al. (2009) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat. Genet., 41, 348-353.
41. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus(1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
42. Hadjadj, S., Fumeron, F., Roussel, R., Saulnier, P.J., Gallois, Y., Ankotche, A., Travert, F., Abi Khalil, C., Miot, A., Alhenc-Gelas, F. et al. (2008) Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: Results from the non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR), diabete de type 2, nephropathie et genetique (DIAB2NEPHROGENE), and survie, diabete de type 2 et genetique (SURDIAGENE) studies. Diabetes Care, 31 1847-1852.
43. Balkau, B. (1996) An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): Epidemiologic data on the insulin resistance syndrome. Rev. Epidemiol. Sante Publique, 44 373-375.
44. Hercberg, S., Preziosi, P., Briancon, S., Galan, P., Triol, I., Malvy, D., Roussel, A.M. and Favier, A. (1998) A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin. Trials, 19 336-351.
45. Branson, R., Potoczna, N., Kral, J.G., Lentes, K.U., Hoehe, M.R. and Horber, F.F. (2003) Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med., 348, 1096-1103.
46. Oberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B. and Patsch, W. (2004) Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes, 53, 1385-1393.
47. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259-266.
48. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. Br. Med. J., 315, 629-634.